‘India's Vaccine Results Likely In 2 To 3 Months'

THE human trial for Covaxin, an experimental novel coronavirus vaccine developed by the Hyderabad-based Bharat Biotech, is set to begin at New Delhi's All India Institute Of Medical Sciences. The researchers are hopeful that the results of Phase 1 of the crucial trial will be out by September or October.

- Milan Sharma

AIIMS-New Delhi is one of the 12 sites chosen by the Indian Council of Medical Research, which is a collaborator on the Covaxin novel coronavirus vaccine project, for conducting human trials of the Covid-19 vaccine candidate. While the ethics committee of the AIIMS New Delhi has already given the human trial a go-ahead, a similar approval is awaited at the other 11 medical facilities.

So far, around 1800 people have registered as volunteers at AIIMS-New Delhi alone.